- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pancreatic Neuroendocrine Tumor G2 in New Zealand
Total 926 results
-
Abramson Cancer Center at Penn MedicineGuerbetActive, not recruitingLiver Metastases | Neuroendocrine Tumor, MalignantUnited States, Canada, Italy, Argentina
-
National Cancer Institute (NCI)Active, not recruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Pancreatic Adenocarcinoma | Metastatic... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedGastro-enteropancreatic Neuroendocrine Tumor | Secondary Malignant Neoplasm of LiverUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage IV Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin | Stage I Neuroendocrine Carcinoma of the SkinUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCCompletedNeuroendocrine Tumors | Metastatic Neuroendocrine TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterCuradev PharmaRecruiting
-
Memorial Sloan Kettering Cancer CenterEMD SeronoRecruitingMerkel Cell CarcinomaUnited States
-
Crinetics Pharmaceuticals Inc.Active, not recruitingCarcinoid Tumor | Carcinoid Syndrome | Carcinoid | Carcinoid Tumor of Ileum | Carcinoid Tumor of Cecum | Carcinoid Syndrome Diarrhea | Carcinoid Intestine Tumor | Carcinoid Tumor of Liver | Carcinoid Tumor of PancreasUnited States, Brazil, Argentina, Canada, Mexico, Peru, Poland
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Xencor, Inc.ICON plcCompletedNeuroendocrine Tumor | Gastrointestinal NeoplasmUnited States
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; Novartis; GI Research FoundationRecruitingMerkel Cell CarcinomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCCompletedPANCREAS | NeuroendocrineUnited States
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Barwon HealthAustralasian Gastro-Intestinal Trials Group; Deakin University; Specialised Therapeutics...UnknownGastrointestinal Neuroendocrine CarcinomasAustralia
-
McGill University Health Centre/Research Institute...Completed
-
Novartis PharmaceuticalsCompleted
-
University of RochesterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
Novartis PharmaceuticalsCompleted
-
Callisto PharmaceuticalsCompletedNeuroendocrine CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMelanoma | Merkel Cell Carcinoma | Other Solid TumorsUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedHigh Grade Malignant Neuroendocrine Carcinoma (Diagnosis)United States
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Head and Neck Cancer | Gynecologic Cancer | Thoracic Cancer | Head and Neck Tumor | Gynecologic Tumor | Thoracic TumorUnited States
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaActive, not recruitingLentigo MalignaAustralia, Brazil, New Zealand
-
Stony Brook UniversityYale University; Columbia University; Icahn School of Medicine at Mount Sinai; Weill... and other collaboratorsUnknownLymphadenopathy | Gastric Tumor | Pancreatic Tumor | Esophageal Tumor | Duodenal TumorUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMelanoma | Solid Tumor | Metastatic Melanoma | NeoplasmUnited States, United Kingdom
-
HutchmedActive, not recruitingNeuroendocrine Tumours | Neuroendocrine Tumour of the Lung | Small Intestinal NETSpain, France, United States, United Kingdom, Norway, Germany, Italy
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Intestine Cancer | Anal Cancer | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer | Gastrointestinal Carcinoid TumorUnited States
-
AbbVieTerminatedGlioblastoma | Medullary Thyroid Cancer | Malignant Melanoma | Other Solid Tumors | Large-Cell Neuroendocrine Carcinoma | Neuroendocrine Prostate Cancer | High Grade Gastroenteropancreatic Neuroendocrine Carcinoma | Other Neuroendocrine CarcinomaUnited States
-
Trans Tasman Radiation Oncology GroupCompleted
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedNeuroendocrine Carcinoma of the SkinUnited States
-
Melanoma and Skin Cancer Trials LimitedRecruitingMetastatic Merkel Cell CarcinomaAustralia
-
Robert RamirezAadi Bioscience, Inc.Terminated
-
Callisto PharmaceuticalsCompletedNeuroendocrine CarcinomaUnited States
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
Trans Tasman Radiation Oncology GroupUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...CompletedLymph Node Disease | Malignant MelanomaAustralia, New Zealand, Netherlands, Brazil
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant TumorNew Zealand, Australia
-
PfizerCompletedHepatocellular Carcinoma | Advanced Breast Cancer | Non-Small Cell Lung Cancer | Metastatic Breast Cancer | Metastatic Renal Cell Cancer | Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Gastrointestinal Stromal Tumor | Advanced Gastric Cancer | Metastatic Castration Resistant Prostate Cancer | Advanced... and other conditionsUnited States, Spain, Korea, Republic of, France, Australia, United Kingdom, Canada, Brazil, Argentina, Taiwan, Belgium, Colombia, Germany, Hong Kong, Mexico, Philippines, Singapore
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Neuroendocrine Neoplasm | Metastatic Neuroendocrine Carcinoma | Metastatic Large Cell Neuroendocrine Carcinoma | Metastatic Small Cell Neuroendocrine CarcinomaUnited States, Canada
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedNeuroendocrine CarcinomaUnited States
-
NeotropixUnknownCarcinoid | NeuroendocrineUnited States
-
ITM Solucin GmbHRecruitingNeuroendocrine TumorsUnited States, United Kingdom, Australia, France, Italy, Netherlands, Spain, Germany, Sweden, India
-
Incyte CorporationActive, not recruitingMetastatic Merkel Cell CarcinomaUnited Kingdom, United States, Germany, Canada, Czechia, Italy, France, Spain, Switzerland, Australia, Poland, Hungary
-
National Cancer Institute (NCI)RecruitingAdvanced Extrapulmonary Neuroendocrine Carcinoma | Metastatic Extrapulmonary Neuroendocrine Carcinoma | Recurrent Extrapulmonary Neuroendocrine Carcinoma | Unresectable Extrapulmonary Neuroendocrine CarcinomaUnited States
-
Columbia UniversityCompleted
-
Prof. Dr. med. Dirk SchadendorfBristol-Myers SquibbActive, not recruitingMerkel Cell CarcinomaGermany, Netherlands
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States